LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 868 | 2839 | 3556 | 0.7980 | 0.7896 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 72 | hr | 868 | 2997 | 3556 | 0.8424 | 0.8377 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 868 | 3338 | 3556 | 0.9381 | 0.9375 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3136 | 3556 | 0.8821 | 0.8804 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 868 | 2729 | 3556 | 0.7678 | 0.7564 |
MDA-MB-231 | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 868 | 2454 | 3556 | 0.6906 | 0.6673 |
MDA-MB-231 | ZSTK474 | 3.33 | uM | LJP6 | 72 | hr | 868 | 2199 | 3556 | 0.6186 | 0.5792 |
MDA-MB-231 | ZSTK474 | 10 | uM | LJP6 | 72 | hr | 868 | 1948 | 3556 | 0.5476 | 0.4867 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 868 | 3067 | 3410 | 0.8984 | 0.8931 |
MDA-MB-231 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3172 | 3410 | 0.9300 | 0.9276 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 868 | 2960 | 3410 | 0.8673 | 0.8601 |
MDA-MB-231 | BX-912 | 1.11 | uM | LJP5 | 72 | hr | 868 | 1867 | 3410 | 0.5472 | 0.4728 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 868 | 1451 | 3410 | 0.4254 | 0.2964 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 72 | hr | 868 | 1363 | 3410 | 0.3990 | 0.2543 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 868 | 3237 | 3556 | 0.9105 | 0.9100 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 868 | 2519 | 3556 | 0.7093 | 0.6893 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 868 | 1974 | 3556 | 0.5549 | 0.4967 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 868 | 1812 | 3556 | 0.5097 | 0.4357 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 868 | 1674 | 3556 | 0.4709 | 0.3809 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 72 | hr | 868 | 1467 | 3556 | 0.4127 | 0.2943 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 868 | 3488 | 3556 | 0.9804 | 0.9802 |
MDA-MB-231 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3092 | 3556 | 0.8704 | 0.8677 |
MDA-MB-231 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 868 | 2762 | 3556 | 0.7775 | 0.7674 |
MDA-MB-231 | MK2206 | 1.11 | uM | LJP6 | 72 | hr | 868 | 2676 | 3556 | 0.7528 | 0.7393 |
MDA-MB-231 | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 868 | 2585 | 3556 | 0.7262 | 0.7080 |